We are international
Donate
• advocacy   TEXT SIZE   
advocacy update    back

ASCO 2010: Dose-escalation study of carfilzomib (CFZ) plus lenalidomide (LEN) plus low-dose dexamethasone (Dex) (CRd) in relapsed/refractory multiple myeloma (R/R MM).
William Bensinger, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington, U.S.A.
06.08.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles